Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Poland

Coordination and Support Action · Running

TrePsy Towards new treatments of psychiatric disorders - a systems-oriented approach

Coordinator
Instytut Farmakologii Im. Jerzego Maja Polskiej Akademii Nauk, Poland
Runs
1 November 2022 to 30 April 2026
Status
Running
EU funding
€1.3m
Total cost
€1.3m
Partners
5 organisations in 4 countries
Type
Coordination and Support Action
Grant agreement
101079256

What the project is doing

In the project's own words, from its summary on CORDIS.

The TrePsy project aims to integrate the Maj Institute of Pharmacology of the Polish Academy of Sciences (IP PAS) with leading European brain research centres in development of novel treatments of psychiatric disorders, strengthen research excellence at the IP PAS, and empower it to become leader in other Horizon Europe projects. To this end we will create a unique advanced research curriculum for students and early-career scientists, who will lead future neuropharmacological research, and form a cluster of institutions of excellence in the fields of Neuropsychopharmacology.

The project will provide students, and PhD programme participants at the Maj Institute of Pharmacology of the Polish Academy of Sciences (IP PAS), as well as partner Institutes, with lectures and training in emerging topics and research methodologies. These activities will be organised through four advanced schools, each including lectures and hands-o training in advanced research methods, and additionally a “University Specialist” course that will be developed by the consortium.

The training activities will be complemented with participation in regional science outreach events, with presentations focused on brain research, the importance of Neuropsychopharmacology-driven research. Furthermore, as an exploratory research project, we selected the study of neuronal and molecular mechanisms involved in the actions of cannabidiol. Each of the partners will contribute their unique research competence including transgenic mice and rats, a ‘multiome’ approach to gene regulation analysis with RNA-Seq and ATAC-Seq, advanced methods of imaging and controlling neuronal activity in behaving animals, and multimodal neuroimaging methodology.

The planned research activities emphasize mutual benefits for all consortium partners, nevertheless, interactions with the three leading European research centres will have the greatest impact on research excellence at the IP PAS.

Who is involved

OrganisationCityCountryRole
Instytut Farmakologii Im. Jerzego Maja Polskiej Akademii NaukKrakowPolandCoordinator
Zentralinstitut Fuer Seelische GesundheitMannheimGermanyParticipant
Universidad Miguel Hernandez De ElcheElcheSpainParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
Universite De BordeauxBordeauxFranceThird party

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI